JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
There are no items in your shopping cart
Featured Products
Axon 3184
CAS [2387704-62-1]
MF C21H20Cl2N10OMW 499.36
SR-4835 is a potent, highly selective and orally bioavailable dual inhibitor of CDK12 and CDK13 (IC50 value of 99 nM for CDK12; Kd values of 98 and 4.9 nM for CDK12 and CDK13, respectively). SR-4835 has potent cell-based and in vivo anti-triple-negative breast cancer (TNBC) activity and augments the anti-cancer activity of cisplatin, irinotecan, and olaparib, which are standard-of-care therapeutics for TNBC.
KEYWORDS: SR-4835 | supplier | CDK12/13 inhibitor | SR 4835 | SR4835 | CAS [2387704-62-1] | Cyclin Dependent (CDK) | CDK | Inhibitor | Enzymes | Triple-negative breast cancer | TNBC
N-((5,6-Dichloro-1H-benzo[d]imidazol-2-yl)methyl)-9-(1-methyl-1H-pyrazol-4-yl)-2-morpholino-9H-purin-6-amine
[2387704-62-1]
The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.
Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!
* Required Fields